Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2h-1-benzopyran-2-one
2. Aldocumar
3. Apo-warfarin
4. Coumadin
5. Coumadine
6. Gen-warfarin
7. Marevan
8. Potassium, Warfarin
9. Sodium, Warfarin
10. Tedicumar
11. Warfant
12. Warfarin
13. Warfarin Potassium
1. 129-06-6
2. Sodium Warfarin
3. Jantoven
4. Aldocumar
5. Athrombin
6. Marevan
7. Zoocoumarin Sodium Salt
8. Warfarin Sodium Salt
9. Apo-warfarin
10. Warfarin (sodium)
11. Sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-2h-chromen-4-olate
12. Warfarin Sodium [usp]
13. 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin Sodium Salt
14. 6153cwm0cl
15. Warfarin Sodium Clathrate
16. 2h-1-benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, Sodium Salt
17. 67430-45-9
18. Coumadine
19. Dicusat
20. Marevam
21. Orfarin
22. Tintorane
23. Varfine
24. Warcoumin
25. Warfarin Sodium (usp)
26. Warfilone
27. Simarc
28. Coumadin Sodium
29. Sodium Coumadin
30. Uniwarfin
31. Ratsul Soluble
32. Coumadan Sodico
33. Coumafene Sodium
34. Warfarinsodium
35. Sodium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate
36. Warfarin, Sodium Salt
37. Caswell No. 903a
38. Warfarin-sodium
39. (+-)-warfarin Sodium
40. Warfarin, Sodium Deriv.
41. Einecs 204-929-4
42. 3-(3-oxo-1-phenylbutyl)-4-sodiooxy-2h-1-benzopyran-2-one
43. Epa Pesticide Chemical Code 086003
44. Unii-6153cwm0cl
45. Warfarinum Natricum
46. Coumadin (tn)
47. Jantoven (tn)
48. Einecs 226-909-4
49. Sodium, ((3-(alpha-acetonylbenzyl)-2-oxo-2h-1-benzopyran-4-yl)oxy)-
50. Warfarin Sodium Clatharate
51. Schembl7826
52. Dsstox_cid_15010
53. Dsstox_rid_79236
54. Dsstox_gsid_35010
55. Mls001074341
56. Warfarin Sodium [vandf]
57. Chembl1200879
58. Dtxsid7035010
59. Warfarin Sodium [mart.]
60. Hy-b0687a
61. Warfarin Sodium [who-dd]
62. Warfarin Sodium [who-ip]
63. Warfarin Sodium Salt [mi]
64. Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-, Sodium Salt
65. Hms2233p10
66. Hms3259g13
67. Hms3369m10
68. Bcp20702
69. Tox21_301545
70. Bdbm50248297
71. Warfarin Sodium [orange Book]
72. Akos015951251
73. Akos015955387
74. Warfarin Sodium [ep Monograph]
75. Ac-8078
76. Cs-w019743
77. Nc00490
78. Warfarin Sodium [usp Monograph]
79. Ncgc00255556-01
80. Ac-19972
81. Cas-129-06-6
82. Smr000058849
83. Warfarinum Natricum [who-ip Latin]
84. W0005
85. Warfarin Sodium (contains Isopropyl Alcohol)
86. D00564
87. O12075
88. A805899
89. J-005647
90. Sodium Warfarin;warf42 Sodium; Athrombine-k Sodium
91. Q27263296
92. 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin Sodiuim Salt
93. 4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin Sodium Salt
94. Sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-1-benzopyran-4-olate
95. 3-(.alpha.-acetonylbenzyl)-4-hydroxycoumarin Sodium Salt
96. Sodium 2-oxidanylidene-3-(3-oxidanylidene-1-phenyl-butyl)chromen-4-olate
97. 2h-1-benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, Sodium Salt (1:1)
Molecular Weight | 330.3 g/mol |
---|---|
Molecular Formula | C19H15NaO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 330.08680324 g/mol |
Monoisotopic Mass | 330.08680324 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 508 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Jantoven |
PubMed Health | Warfarin |
Drug Classes | Anticoagulant |
Drug Label | JantovenTablets (crystalline warfarin sodium) is an anticoagulant which acts by inhibiting vitamin K-dependent coagulation factors. Chemically, it is 3-(and is a racemic mixture of the R- and S-enantiomers. Crystalline warfarin sodium is an isopropan... |
Active Ingredient | Warfarin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 7.5mg; 1mg; 5mg; 4mg; 6mg; 2mg; 10mg; 3mg |
Market Status | Prescription |
Company | Usl Pharma |
2 of 4 | |
---|---|
Drug Name | Warfarin sodium |
Drug Label | Warfarin sodium tablet (crystalline warfarin sodium) is an anticoagulant, which acts by inhibiting vitamin K-dependent coagulation factors. Chemically, it is 3-(and is a racemic mixture of the R- and S-enantiomers. Crystalline warfarin sodium is an i... |
Active Ingredient | Warfarin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 7.5mg; 1mg; 5mg; 4mg; 6mg; 2mg; 10mg; 3mg |
Market Status | Prescription |
Company | Amneal Pharms; Taro; Invagen Pharms; Ipca Labs; Zydus Pharms Usa; Pliva; Mylan; Barr |
3 of 4 | |
---|---|
Drug Name | Jantoven |
PubMed Health | Warfarin |
Drug Classes | Anticoagulant |
Drug Label | JantovenTablets (crystalline warfarin sodium) is an anticoagulant which acts by inhibiting vitamin K-dependent coagulation factors. Chemically, it is 3-(and is a racemic mixture of the R- and S-enantiomers. Crystalline warfarin sodium is an isopropan... |
Active Ingredient | Warfarin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 7.5mg; 1mg; 5mg; 4mg; 6mg; 2mg; 10mg; 3mg |
Market Status | Prescription |
Company | Usl Pharma |
4 of 4 | |
---|---|
Drug Name | Warfarin sodium |
Drug Label | Warfarin sodium tablet (crystalline warfarin sodium) is an anticoagulant, which acts by inhibiting vitamin K-dependent coagulation factors. Chemically, it is 3-(and is a racemic mixture of the R- and S-enantiomers. Crystalline warfarin sodium is an i... |
Active Ingredient | Warfarin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 7.5mg; 1mg; 5mg; 4mg; 6mg; 2mg; 10mg; 3mg |
Market Status | Prescription |
Company | Amneal Pharms; Taro; Invagen Pharms; Ipca Labs; Zydus Pharms Usa; Pliva; Mylan; Barr |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Rodenticides
Substances used to destroy or inhibit the action of rats, mice, or other rodents. (See all compounds classified as Rodenticides.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22132
Submission : 2008-11-11
Status : Active
Type : II
NDC Package Code : 63278-1058
Start Marketing Date : 1983-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : R1-CEP 2014-183 - Rev 00
Issue Date : 2021-07-13
Type : Chemical
Substance Number : 698
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12746
Submission : 1997-11-18
Status : Active
Type : II
Certificate Number : R1-CEP 2001-285 - Rev 05
Issue Date : 2017-08-24
Type : Chemical
Substance Number : 698
Status : Valid
Certificate Number : R1-CEP 2001-372 - Rev 04
Issue Date : 2018-11-16
Type : Chemical
Substance Number : 699
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21925
Submission : 2008-08-25
Status : Active
Type : II
Certificate Number : R1-CEP 2008-321 - Rev 01
Issue Date : 2018-11-16
Type : Chemical
Substance Number : 698
Status : Valid
Date of Issue : 2021-03-12
Valid Till : 2024-01-24
Written Confirmation Number : WC-0291n
Address of the Firm :
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36406
Submission : 2021-10-14
Status : Active
Type : II
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23289
Submission : 2009-11-20
Status : Active
Type : II
Date of Issue : 2021-09-06
Valid Till : 2020-04-22
Written Confirmation Number : WC-0305
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21926
Submission : 2008-08-25
Status : Inactive
Type : II
Certificate Number : CEP 2021-450 - Rev 00
Issue Date : 2024-02-05
Type : Chemical
Substance Number : 699
Status : Valid
Date of Issue : 2018-01-25
Valid Till : 2021-01-24
Written Confirmation Number : WC-0291
Address of the Firm :
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12117
Submission : 1996-08-27
Status : Inactive
Type : II
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22132
Submission : 2008-11-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12746
Submission : 1997-11-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11387
Submission : 1995-03-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2467
Submission : 1975-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21680
Submission : 2008-08-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12117
Submission : 1996-08-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12269
Submission : 1996-12-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12977
Submission : 1998-05-02
Status : Active
Type : II
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : R1-CEP 2014-183 - Rev 00
Status : Valid
Issue Date : 2021-07-13
Type : Chemical
Substance Number : 698
Certificate Number : R1-CEP 2001-372 - Rev 04
Status : Valid
Issue Date : 2018-11-16
Type : Chemical
Substance Number : 699
Certificate Number : R1-CEP 2001-285 - Rev 05
Status : Valid
Issue Date : 2017-08-24
Type : Chemical
Substance Number : 698
Certificate Number : R1-CEP 2013-233 - Rev 00
Status : Valid
Issue Date : 2020-02-06
Type : Chemical
Substance Number : 698
Warfarin sodium, amorphous; amorphous, ground
Certificate Number : R1-CEP 1997-005 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2010-06-30
Type : Chemical
Substance Number : 698
Certificate Number : R1-CEP 2009-041 - Rev 02
Status : Valid
Issue Date : 2019-06-17
Type : Chemical
Substance Number : 698
Certificate Number : R1-CEP 2000-186 - Rev 05
Status : Valid
Issue Date : 2018-02-26
Type : Chemical
Substance Number : 698
Certificate Number : R0-CEP 2004-125 - Rev 01
Status : Expired
Issue Date : 2008-01-17
Type : Chemical
Substance Number : 698
Certificate Number : R0-CEP 2013-083 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-04-14
Type : Chemical
Substance Number : 699
Certificate Number : R0-CEP 2015-059 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2016-12-02
Type : Chemical
Substance Number : 698
Date of Issue : 2020-06-25
Valid Till : 2021-12-22
Written Confirmation Number : WC-0348
Address of the Firm : A-14, SIDCO Pharmaceutical Complex, Alathur, Dist. Kancheepuram-603110
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm : API Division Kharakhadi, Plot No. 842-843, Kharakhadi, Padra Vadodara-391 450, G...
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm : Sejavta, Ratlam, Madhya Pradesh
Warfarin Sodium Clatharate USP
Date of Issue : 2021-09-06
Valid Till : 2020-04-22
Written Confirmation Number : WC-0305
Address of the Firm : Plot No. 68 Jawaharlal Nehru Pharma City, Parawada (M), Visakhapatnam, A.P
Date of Issue : 2021-03-12
Valid Till : 2024-01-24
Written Confirmation Number : WC-0291n
Address of the Firm : Survey No. 69, Chandrapadiya (V), Vinjamur Mandal, Nellore District-524228
Date of Issue : 2018-01-25
Valid Till : 2021-01-24
Written Confirmation Number : WC-0291
Address of the Firm : Survey No. 69, Chandrapadiya (V), Vinjamur Mandal, Nellore District-524228
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 1076-38-6
End Use API : Warfarin Sodium
About The Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API...
CAS Number : 118-93-4
End Use API : Warfarin Sodium
About The Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API...
CAS Number : 1076-38-6
End Use API : Warfarin Sodium
About The Company : Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Inter...
CAS Number : 1076-38-6
End Use API : Warfarin Sodium
About The Company : Maisuriya Pharma Solutions is a research-driven & technology-oriented company. Continuous innovations & improvement are the lifeblood of our business. Our major...
CAS Number : 93-35-6
End Use API : Warfarin Sodium
About The Company : SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry....
Regulatory Info :
Registration Country : Sweden
Brand Name : Warfarin Orion
Dosage Form : TABLET
Dosage Strength : 2.5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Warfarin Orion
Dosage Form : Antic-calc Tablet
Dosage Strength : 2.5 mg
Packaging : Box of plastic
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Coumadin
Dosage Form : Warfarin 5Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR Div 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Coumadin
Dosage Form : TABLET
Dosage Strength : 2.5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Marevan
Dosage Form : Antic-calc Tablet
Dosage Strength : 2.5 mg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 60
2016 Revenue in Millions : 67
Growth (%) : -11
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 50
2017 Revenue in Millions : 56
Growth (%) : -11%
Market Place
Reply
02 Sep 2024
Reply
09 Apr 2024
Reply
02 Feb 2023
Reply
13 Dec 2022
Reply
13 Jul 2022
Reply
11 Jun 2022
Reply
30 Jan 2021
Reply
13 May 2020
Reply
12 Feb 2020
Reply
23 Sep 2019
REF. STANDARDS & IMPURITIES
Warfarin sodium
CAS Number :
Quantity Per Vial : 10 mg
Sale Unit : 1
Order Code : W010000 0
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
Warfarin sodium clathrate
CAS Number : N/A
Quantity Per Vial : 10 mg
Sale Unit : 1
Order Code : Y0000778
Batch No : 1
Price (€) : 79
Storage : +5°C ± 3°C
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?